Literature DB >> 16278902

Majewski osteodysplastic primordial dwarfism type II (MOPD II) complicated by stroke: clinical report and review of cerebral vascular anomalies.

Francesco Brancati1, Marco Castori, Rita Mingarelli, Bruno Dallapiccola.   

Abstract

We report on a 2 9/12-year-old boy with disproportionate short stature, microcephaly, subtle craniofacial dysmorphisms, and generalized skeletal dysplasia, who developed a left hemiparesis. Brain neuroimaging disclosed a complex cerebral vascular anomaly (CVA) with stenosis of the right anterior cerebral artery and telangiectatic collateral vessels supplying the cerebral cortex, consistent with moyamoya disease. Based on clinical and skeletal features, a diagnosis of Majewski osteodysplastic primordial dwarfism type II (MOPD II) was established. Review of 16 published patients with CVA affected by either Seckel syndrome or MOPD II suggested that CVA is preferentially associated to the latter subtype affecting about 1/4 of the patients. 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 16278902     DOI: 10.1002/ajmg.a.31009

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  16 in total

1.  Majewski dwarfism type II: an atypical neuroradiological presentation with a novel variant in the PCNT gene.

Authors:  Hamdan Alrajhi; Jubara Alallah; Aiman Shawli; Khalid Alghamdi; Fahad Hakami
Journal:  BMJ Case Rep       Date:  2019-05-30

2.  Microcephalic osteodysplastic primordial dwarfism type II is associated with global vascular disease.

Authors:  Angela L Duker; Dagmar Kinderman; Christy Jordan; Tim Niiler; Carissa M Baker-Smith; Louise Thompson; David A Parry; Ricki S Carroll; Michael B Bober
Journal:  Orphanet J Rare Dis       Date:  2021-05-20       Impact factor: 4.123

3.  PCNT point mutations and familial intracranial aneurysms.

Authors:  Oswaldo Lorenzo-Betancor; Patrick R Blackburn; Emily Edwards; Rocío Vázquez-do-Campo; Eric W Klee; Catherine Labbé; Kyndall Hodges; Patrick Glover; Ashley N Sigafoos; Alexandra I Soto; Ronald L Walton; Stephen Doxsey; Michael B Bober; Sarah Jennings; Karl J Clark; Yan Asmann; David Miller; William D Freeman; James Meschia; Owen A Ross
Journal:  Neurology       Date:  2018-11-09       Impact factor: 9.910

4.  Moyamoya-like vasculopathy and Seckel syndrome: just a coincidence?

Authors:  Ralph Rahme; Louis Crevier; Josée Dubois; Claude Mercier
Journal:  Childs Nerv Syst       Date:  2010-07       Impact factor: 1.475

5.  Medical management of moyamoya disease and recurrent stroke in an infant with Majewski osteodysplastic primordial dwarfism type II (MOPD II).

Authors:  Esra Kılıç; Eda Utine; Sule Unal; Göknur Haliloğlu; Kader Karli Oğuz; Mualla Cetin; Koray Boduroğlu; Yasemin Alanay
Journal:  Eur J Pediatr       Date:  2012-04-17       Impact factor: 3.183

6.  Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya.

Authors:  Snaigune Miskinyte; Matthew G Butler; Dominique Hervé; Catherine Sarret; Marc Nicolino; Jacob D Petralia; Francoise Bergametti; Minh Arnould; Van N Pham; Aniket V Gore; Konstantinos Spengos; Steven Gazal; France Woimant; Gary K Steinberg; Brant M Weinstein; Elisabeth Tournier-Lasserve
Journal:  Am J Hum Genet       Date:  2011-05-19       Impact factor: 11.025

7.  Identification of two novel critical mutations in PCNT gene resulting in microcephalic osteodysplastic primordial dwarfism type II associated with multiple intracranial aneurysms.

Authors:  Fei-Feng Li; Xu-Dong Wang; Min-Wei Zhu; Zhi-Hong Lou; Qiong Zhang; Chun-Yu Zhu; Hong-Lin Feng; Zhi-Guo Lin; Shu-Lin Liu
Journal:  Metab Brain Dis       Date:  2015-08-01       Impact factor: 3.584

8.  Identification of three novel mutations in PCNT in vietnamese patients with microcephalic osteodysplastic primordial dwarfism type II.

Authors:  Thu Hien Nguyen; Ngoc-Lan Nguyen; Chi Dung Vu; Can Thi Bich Ngoc; Ngoc Khanh Nguyen; Huy Hoang Nguyen
Journal:  Genes Genomics       Date:  2021-01-18       Impact factor: 1.839

9.  Clinical and functional characterization of a patient carrying a compound heterozygous pericentrin mutation and a heterozygous IGF1 receptor mutation.

Authors:  Eva Müller; Desiree Dunstheimer; Jürgen Klammt; Daniela Friebe; Wieland Kiess; Jürgen Kratzsch; Tassilo Kruis; Sandy Laue; Roland Pfäffle; Tillmann Wallborn; Peter H Heidemann
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

10.  Pericentrin in health and disease: Exploring the patchwork of Pericentrin splice variants.

Authors:  Johanna Mühlhans; Andreas Gießl
Journal:  Commun Integr Biol       Date:  2012-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.